Evidence map›Paper›PMID 32058996›Full record

ArticlePLoS computational biology2020

Enhancing reproducibility of gene expression analysis with known protein functional relationships: The concept of well-associated protein.

Joël R Pradines, Victor Farutin, Nicholas A Cilfone, Abouzar Ghavami, Elma Kurtagic, Jamey Guess, Anthony M Manning, Ishan Capila

Abstract read
In one paragraph

Article in PLoS computational biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joël R PradinesMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.
Victor FarutinMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-9220-1461
Nicholas A CilfoneMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-6490-4418
Abouzar GhavamiMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.ORCID 0000-0001-5772-0285
Elma KurtagicMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.
Jamey GuessMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-4017-0923
Anthony M ManningMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-7743-5489
Ishan CapilaMomenta Pharmaceuticals, 301 Binney Street, Cambridge, Massachusetts, United States of America.ORCID 0000-0002-5036-6778

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of differentially expressed genes (DEGs) is well recognized to be variable across independent replications of genome-wide transcriptional studies. These are often employed to characterize disease state early in the process of discovery and prioritize novel targets aimed at addressing unmet medical need. Increasing reproducibility of biological findings from these studies could potentially positively impact the success rate of new clinical interventions. This work demonstrates that statistically sound combination of gene expression data with prior knowledge about biology in the form of large protein interaction networks can yield quantitatively more reproducible observations from studies characterizing human disease. The novel concept of Well-Associated Proteins (WAPs) introduced herein-gene products significantly associated on protein interaction networks with the differences in transcript levels between control and disease-does not require choosing a differential expression threshold and can be computed efficiently enough to enable false discovery rate estimation via permutation. Reproducibility of WAPs is shown to be on average superior to that of DEGs under easily-quantifiable conditions suggesting that they can yield a significantly more robust description of disease. Enhanced reproducibility of WAPs versus DEGs is first demonstrated with four independent data sets focused on systemic sclerosis. This finding is then validated over thousands of pairs of data sets obtained by random partitions of large studies in several other diseases. Conditions that individual data sets must satisfy to yield robust WAP scores are examined. Reproducible identification of WAPs can potentially benefit drug target selection and precision medicine studies.

Indexed as

Gene Expression ProfilingProtein Interaction MapsArea Under CurveComputational BiologyFalse Positive ReactionsGene Expression RegulationHumansLinear ModelsMultivariate AnalysisPrecision MedicineProbabilityProteinsReproducibility of ResultsScleroderma, SystemicProteins

Identifiers

PMID32058996
PMCPMC7046299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.